Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Merck KGaA gains exclusive rights to Debiopharma’s late-stage oncology asset

Merck KGaA gains exclusive rights to Debiopharma’s late-stage oncology asset

Merck KGaA will pay Debiopharm 188m upfront and up to 710m in regulatory and commercial milestones, as well as royalty payments, for the exclusive rights to xevinapant. ... high unmet need where other approaches, including immunotherapy, have seen

Trial failure for bintrafusp alfa casts doubt on GSK/Merck KGaA’s cancer alliance

Trial failure for bintrafusp alfa casts doubt on GSK/Merck KGaA’s cancer alliance Bispecific antibody fails in non-small cell lung cancer trial. Bintrafusp alfa – the novel immunotherapy at the centre of a major alliance between GlaxoSmithKline (GSK) and Merck KGaA – has failed in ... program,” said Danny Bar-Zohar, global head

Merck KGaA signs deal with Artios Pharma potentially worth up to $860m

Merck KGaA signs deal with Artios Pharma potentially worth up to $860m Under the terms of the agreement, Merck KGaA will pay Artios $30m upfront, as well as near-term payments. ... Artios could also receive royalty payments up to double digits on net sales of each product commercialised by Merck KGaA.

Pierre Fabre’s Braftovi scores NICE backing for BRAF+ colorectal cancer

Pierre Fabre’s Braftovi scores NICE backing for BRAF+ colorectal cancer Drug approved in combination with Merck's KGaA's Erbitux. French pharma group Pierre Fabre’s Braftovi has been recommended for NHS use by the UK’s National Institute for Health ... Braftovi (encorafenib) combined with has been recommended Merck

Switzerland: a life sciences hub

Switzerland: a life sciences hub When Merck acquired Serono, the company also acquired several manufacturing facilities in the canton of Vaud. ... The country is thus home to AbbVie, Allergan, Amgen, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline,

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams....
The power of communication: Engaging diverse groups in healthcare
Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...
Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....